Actively Recruiting

Phase 3
Age: 8Years - 18Years
All Genders
ID06865417

A Multicenter Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Filgotinib, With Single Arm Induction and Maintenance, in Pediatric Subjects (8 to <18 Years of Age) With Moderately to Severely Active Ulcerative Colitis

Led by Alfasigma S.p.A. · Updated on 2026-02-06

80

Participants Needed

51

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating filgotinib in children and adolescents aged 8 to less than 18 years with moderately to severely active ulcerative colitis (UC). This study aims to assess the medicine's efficacy, safety, tolerability, and how the body processes it. About 80 participants will be enrolled, including at least 8 children aged 8 to under 12 years. The study focuses on those who have had insufficient response or intolerance to other treatments like corticosteroids or biologics. Participants will take filgotinib tablets once daily in the morning, with or without food. Doses are designed to achieve similar blood levels as seen in adults treated with 200 mg daily. On-site dosing will occur at Weeks 4, 10, and 22, while other doses are taken at home. Those not showing remission or response by Week 10 will continue induction treatment until Week 22. If remission is not reached by Week 22, participants will stop the study treatment. During the study, researchers will monitor participants' health, collecting data on remission rates and response at Week 10 and beyond. Safety and tolerability will be assessed through Week 58 and Week 62. Participants will have regular visits to take medicines, report symptoms, and undergo examinations. The total participation time can last over a year as the study tracks long-term effects and treatment outcomes.

CONDITIONS

Brief Title

A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis

Who Can Participate

Age: 8Years - 18Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Participant must weigh at least 15 kg
  • Aged 8 to less than 18 years
  • Have a documented diagnosis of ulcerative colitis lasting at least 3 months
  • Have a modified Mayo Clinic Score (mMCS) between 5 to 9
  • Have an endoscopic Mayo Clinic Score (MCS) of 2 or higher
  • Have rectal bleeding score of 1 or higher
  • Have stool frequency score of 1 or higher
  • Have had inadequate response, loss of response, intolerance, or contraindications to corticosteroids, immunosuppressants, or biologic therapy
  • Includes those dependent on corticosteroids who worsen when tapering off
Not Eligible

You will not qualify if you...

  • Diagnosis of inflammatory bowel disease unclassified, indeterminate colitis, isolated proctitis, or toxic megacolon
  • Active infection at the time of screening
  • History of complicated herpes zoster infection involving multiple dermatomes, dissemination, eyes, or central nervous system
  • Currently on therapy for chronic infections like pneumocystis, cytomegalovirus, herpes simplex, herpes zoster, or atypical mycobacteria
  • History of colectomy or extensive small bowel resection
  • Psychological or cognitive difficulties interfering with participation
  • Previous exposure to Janus kinase inhibitors or similar medications (e.g., tofacitinib, baricitinib, upadacitinib)
  • Female participants who are pregnant, breastfeeding, or intending to become pregnant or breastfeed during the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Up to 58 weeks

Participants receive daily oral Filgotinib to treat moderately to severely active ulcerative colitis.

Regular visits throughout treatment period

Follow-up

Duration - Up to 4 weeks after treatment

Participants are monitored for safety and tolerability of Filgotinib after treatment ends.

1 to 2 visits (in-person)

Trial Site Locations

Total: 51 locations

1

Association Hospitaliere De Bruxelles Hopital Universitaire Des Enfants Reine Fabiola

Brussels, Brussels Capital, Belgium, 1020

Not Yet Recruiting

2

Centre Hospitalier Regional De La Citadelle

Liège, Liege, Belgium, 4000

Actively Recruiting

3

Centre Hospitalier Universitaire Dinant Godinne Sainte-Elisabeth-UCL-Namur

Namur, Namur, Belgium, 5000

Not Yet Recruiting

4

Klinicki Bolnicki Centar Osijek

Osijek, Croatia, Croatia, 31000

Not Yet Recruiting

5

Children's Hospital Zagreb

Zagreb, Croatia, Croatia, 10000

Actively Recruiting

6

University Hospital Centre Zagreb

Zagreb, Croatia, Croatia, 10000

Actively Recruiting

7

Hospital Femme Mere Enfant

Bron, France, France, 69500

Actively Recruiting

8

Centre Hospitalier Universitaire De Dijon

Dijon, France, France, 21000

Actively Recruiting

9

Hopital Saint Vincent de Paul - GHICL Lille

Lille, France, France, 59020

Actively Recruiting

10

CHU de Montpellier

Montpellier, France, France, 34295

Actively Recruiting

11

Centre Hospitalier Universitaire De Rennes

Rennes, France, France, 35200

Actively Recruiting

12

Centre Hospitalier Regional Universitaire De Tours

Tours, France, France, 37000

Actively Recruiting

13

Universitaetsklinikum Aachen AöR

Aachen, Germany, Germany, 52074

Actively Recruiting

14

Universitaetsklinikum Leipzig AöR

Leipzig, Germany, Germany, 04103

Actively Recruiting

15

Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR

Mainz, Germany, Germany, 55131

Actively Recruiting

16

Universitaetsklinikum Tuebingen AöR

Tübingen, Germany, Germany, 72076

Actively Recruiting

17

Athens General Children's Hospital Panagioti And Aglaia Kyriakou

Athens, Greece, Greece, 11527

Not Yet Recruiting

18

University General Hospital Attikon

Athens, Greece, Greece, 12462

Actively Recruiting

19

General Hospital Of Thessaloniki Papageorgiou

Efkarpia, Greece, Greece, 56429

Actively Recruiting

20

Hippokration Hospital

Thessaloniki, Greece, Greece, 54642

Actively Recruiting

21

Children's Health Ireland

Dublin, Ireland, Ireland, D12 PN40

Not Yet Recruiting

22

Azienda Ospedaliero-Universitaria Ss Antonio E Biagio E Cesare Arrigo

Alessandria, Italy, Italy, 15121

Actively Recruiting

23

Azienda Ospedaliero Universitaria dell Marche I G M Lancisi G Salesi

Ancona, Italy, Italy, 60123

Actively Recruiting

24

ASST Fatebenefratelli Sacco

Milan, Italy, Italy, 20154

Actively Recruiting

25

Azienda Ospedaliera Universitaria Federico II Di Napoli

Naples, Italy, Italy, 80131

Actively Recruiting

26

Azienda Ospedaliero-Universitaria Policlinico Umberto I

Rome, Italy, Italy, 00161

Actively Recruiting

27

Ospedale Pediatrico Bambino Gesu

Rome, Italy, Italy, 00165

Actively Recruiting

28

IRCCS Materno Infantile Burlo Garofolo

Trieste, Italy, Italy, 34137

Actively Recruiting

29

Oslo University Hospital HF

Oslo, Norway, Norway, 0372

Actively Recruiting

30

Sykehuset I Vestfold HF

Tønsberg, Norway, Norway, 3116

Actively Recruiting

31

In Vivo Sp. z o.o.

Bydgoszcz, Poland, Poland, 85-048

Actively Recruiting

32

Copernicus Podmiot Leczniczy Sp. z o.o.

Gdansk, Poland, Poland, 80-803

Not Yet Recruiting

33

Uniwersytecki Szpital Dzieciecy W Krakowie

Krakow, Poland, Poland, 30-663

Not Yet Recruiting

34

Instytut Centrum Zdrowia Matki Polki

Lodz, Poland, Poland, 93-338

Not Yet Recruiting

35

Gabinet Lekarski Bartosz Korczowski

Rzeszów, Poland, Poland, 35-302

Actively Recruiting

36

Instytut Pomnik Centrum Zdrowia Dziecka

Warsaw, Poland, Poland, 04-730

Actively Recruiting

37

CCAB Centro Clinico Academico Braga Associacao

Braga, Portugal, Portugal, 4710-243

Actively Recruiting

38

Hospital Pediátrico de Coimbra

Coimbra, Portugal, Portugal, 3000-602

Actively Recruiting

39

Unidade Local De Saude Do Alto Minho E.P.E.

Viana do Castelo, Portugal, Portugal, 4904-858

Actively Recruiting

40

Dr. Victor Gomoiu Clinical Children Hospital

Bucharest, Romania, Romania, 022102

Actively Recruiting

41

Spitalul Clinic De Urgenta Pentru Copii Louis Turcanu Timisoara

Timișoara, Romania, Romania, 300011

Actively Recruiting

42

Hospital Germans Trias I Pujol

Badalona, Spain, Spain, 08916

Not Yet Recruiting

43

Hospital Universitario Reina Sofia

Córdoba, Spain, Spain

Actively Recruiting

44

Bristol Royal Infirmary

Bristol, United Kingdom, BS2 8HW

Actively Recruiting

45

Noah's Ark Children's Hospital

Cardiff, United Kingdom, CF14 4XW

Not Yet Recruiting

46

Ninewells Hospital

Glasgow, United Kingdom, G51 4TF

Not Yet Recruiting

47

Alder Hey Children's Hospital

Liverpool, United Kingdom

Not Yet Recruiting

48

Chelsea and Westminster Hospital

London, United Kingdom, SW10 9NH

Not Yet Recruiting

49

The Newcastle upon Tyne Hospital FT

Newcastle, United Kingdom, NE1 4LP

Not Yet Recruiting

50

John Radcliffe Hospital

Oxford, United Kingdom, OX3 9DU

Not Yet Recruiting

51

Sheffield Children's Hospital

Sheffield, United Kingdom, S10 2TH

Actively Recruiting

Loading map...

Research Team

V

Vincenzo Teneggi, MD

A

Alexandra Mangili, MD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Similar Trials

A Biospecimen Collection Study to Identify the Targets of Di...

Autoimmune Diseases

Actively Recruiting

12 locations

A Phase 2 Open-Label Extension Trial Evaluating Long-term Sa...

Crohn's Disease

Actively Recruiting

16 locations

A Phase 3b Extension Study to Evaluate the Long-term Safety ...

Ulcerative Colitis

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here